@CowenResearch: Boris Peaker initiates coverage of $TRIL - attempting to address novel target (CD47) ubiquitously expressed on #cancer cells #biotechnology
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.